41.1% retired, respectively)
The platforms stated current offerings include: Injectable GLP-1s: Compounded semaglutide (injectable), Wegovy, Ozempic, Zepbound, Mounjaro, and generic liraglutide, available for eligible patients depending on state and current supply Following the March 2026 Novo Nordisk deal, access to branded Ozempic is now part of the platform Oral Medication Kits: Personalized oral kits combining medications such as bupropion/naltrexone, metformin, and topiramate, targeting food noise, slow metabolism, and appetite regulation without injections App and Support: 360 care, including nutritional principles, behavioral programs, and custom lessons in the Hims app
Does GLP-1 therapy reduce the need for frequent visits
These medications help stabilize blood sugar levels, promote weight loss, and even improve heart health